Further, using a dehydroepiandrosterone (DHEA)-treated PCOS mouse model, Singh et al. showed that exogenous adiponectin treatment enhanced the ovarian expression of insulin receptors and decreased theca androgen synthesis [168], which was accompanied by restored ovulation and normalised circulating androgens and glucose levels [169]. Here, ADIPOQ is linked to polycystic ovary syndrome.